Literature DB >> 10651126

Crystallization in the nephron.

I Højgaard, H G Tiselius.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10651126     DOI: 10.1007/s002400050127

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


× No keyword cloud information.
  7 in total

Review 1.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

2.  Reverse engineering the kidney: modelling calcium oxalate monohydrate crystallization in the nephron.

Authors:  A Borissova; G E Goltz; J P Kavanagh; T A Wilkins
Journal:  Med Biol Eng Comput       Date:  2010-04-28       Impact factor: 2.602

Review 3.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

4.  Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.

Authors:  Hans-Göran Tiselius; Bengt Lindbäck; Anne-Marie Fornander; Mari-Anne Nilsson
Journal:  Urol Res       Date:  2009-05-15

Review 5.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

6.  An understanding of renal stone development in a mixed oxalate-phosphate system.

Authors:  Xiangying Guan; Lijun Wang; Anja Dosen; Ruikang Tang; Rossman F Giese; Jennifer L Giocondi; Christine A Orme; John R Hoyer; George H Nancollas
Journal:  Langmuir       Date:  2008-06-17       Impact factor: 3.882

7.  Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells.

Authors:  Juthatip Manissorn; Kedsarin Fong-Ngern; Paleerath Peerapen; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.